SCHEMBL3093060

SCHEMBL3093060

Cc1c(S)sc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.50
ALDH1A1 P00352 4/20 0.44
PRNP P04156 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
ROCK1 Q13464 1/20 0.40
HSD11B1 P28845 1/20 0.38
MAPT P10636 4/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
GAA P10253 2/20 0.38
POLB P06746 1/20 0.38
TUBB4A P04350 1/20 0.37
TUBB P07437 1/20 0.37
TUBA3C P0DPH7 1/20 0.37
TUBA1B P68363 1/20 0.37
TUBA4A P68366 1/20 0.37
TUBB4B P68371 1/20 0.37
TUBB3 Q13509 1/20 0.37
TUBB2A Q13885 1/20 0.37
TUBB8 Q3ZCM7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3603009 0.77 GPR3 (0.50) GPR3ALDH1A1PRNPRXFP1ROCK1
SCHEMBL26737371 0.76 GPR3 (0.55) GPR3ALDH1A1MAPTMEN1KMT2A
SCHEMBL144440 0.76 GPR3 (0.55) GPR3ALDH1A1PRNPRXFP1ROCK1
Ammonia Solution, Strong SCHEMBL28459123 0.74 GPR3 (0.52) GPR3ALDH1A1PRNPRXFP1ROCK1
SCHEMBL19135547 0.74 GPR3 (0.52) GPR3ALDH1A1MAPTMEN1KMT2A
SCHEMBL9407733 0.73 GPR3 (0.50) GPR3ALDH1A1PRNPRXFP1ROCK1
SCHEMBL6829987 0.73 MAPT (0.52) GPR3ALDH1A1MAPTMEN1KMT2A
SCHEMBL1121831 0.73 GPR3 (0.50) GPR3ALDH1A1PRNPRXFP1ROCK1
SCHEMBL16900681 0.73 GPR3 (0.50) GPR3ALDH1A1PRNPRXFP1ROCK1
SCHEMBL14619935 0.73 GPR3 (0.50) GPR3ALDH1A1PRNPRXFP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023063884-A2 GENERATION OF CHIRAL SULFINATE ESTERS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2023-04-20 WO disclosed
US-20170020858-A1 COMPOUNDS FOR MODULATING TRPV3 FUNCTION HYDRA BIOSCIENCES INC (US) 2017-01-26 US disclosed
US-20170020858-A1 COMPOUNDS FOR MODULATING TRPV3 FUNCTION HYDRA BIOSCIENCES INC (US) 2017-01-26 US disclosed
US-20170020858-A1 COMPOUNDS FOR MODULATING TRPV3 FUNCTION HYDRA BIOSCIENCES INC (US) 2017-01-26 US disclosed
WO-2016039691-A1 CATALYSTS FOR MAKING CHIRAL HETEROCYCLIC SULFOXIDES NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2016-03-17 WO disclosed
US-20150299225-A1 COMPOUNDS FOR MODULATING TRPV3 FUNCTION HYDRA BIOSCIENCES, INC. (US) 2015-10-22 US disclosed
US-20150299225-A1 COMPOUNDS FOR MODULATING TRPV3 FUNCTION HYDRA BIOSCIENCES, INC. (US) 2015-10-22 US disclosed
US-20150299225-A1 COMPOUNDS FOR MODULATING TRPV3 FUNCTION HYDRA BIOSCIENCES, INC. (US) 2015-10-22 US disclosed
US-8916550-B2 Compounds for modulating TRPV3 function HYDRA BIOSCIENCES, INC. (US) 2014-12-23 US disclosed
US-8916550-B2 Compounds for modulating TRPV3 function HYDRA BIOSCIENCES, INC. (US) 2014-12-23 US disclosed
US-20100273777-A1 Compounds for Modulating TRPV3 Function HYDRA BIOSCIENCES, INC. (US) 2010-10-28 US disclosed
US-7803790-B2 Compounds for modulating TRPV3 function HYDRA BIOSCIENCES, INC. (US) 2010-09-28 US disclosed
US-7803790-B2 Compounds for modulating TRPV3 function HYDRA BIOSCIENCES, INC. (US) 2010-09-28 US disclosed
US-7803790-B2 Compounds for modulating TRPV3 function HYDRA BIOSCIENCES, INC. (US) 2010-09-28 US disclosed
WO-2008060626-A9 COMPOUNDS FOR MODULATING TRPV3 FUNCTION HYDRA BIOSCIENCES INC (US) 2008-07-31 WO disclosed
WO-2008060626-A2 COMPOUNDS FOR MODULATING TRPV3 FUNCTION HYDRA BIOSCIENCES, INC. (US) 2008-05-22 WO disclosed
US-20070213321-A1 Compounds for modulating TRPV3 function HYDRA BIOSCIENCES, INC. (US) 2007-09-13 US disclosed
US-20070213321-A1 Compounds for modulating TRPV3 function HYDRA BIOSCIENCES, INC. (US) 2007-09-13 US disclosed
US-20070213321-A1 Compounds for modulating TRPV3 function HYDRA BIOSCIENCES, INC. (US) 2007-09-13 US disclosed
US-20060270688-A1 Compounds for modulating TRPV3 function HYDRA BIOSCIENCES, INC. (US) 2006-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060270688-A1 Compounds for modulating TRPV3 function TRPV3, TRPV1, TRPV4 GPR3 19/4885ALDH1A1 3074/4885PRNP 4228/4885
US-20170020858-A1 COMPOUNDS FOR MODULATING TRPV3 FUNCTION TRPV3, TRPV1, TRPV4 GPR3 19/4885ALDH1A1 3074/4885PRNP 4228/4885
US-20150299225-A1 COMPOUNDS FOR MODULATING TRPV3 FUNCTION TRPV3, TRPV1, TRPV4 GPR3 19/4885ALDH1A1 3074/4885PRNP 4228/4885
US-20100273777-A1 Compounds for Modulating TRPV3 Function TRPV3, TRPV1, TRPV4 GPR3 19/4885ALDH1A1 3074/4885PRNP 4228/4885
US-20070213321-A1 Compounds for modulating TRPV3 function TRPV3, TRPV1, TRPV4 GPR3 19/4885ALDH1A1 3074/4885PRNP 4228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.